{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:45Z","timestamp":1786119405021,"version":"build-2736575974"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/nrl.0b013e3181b1d5c6","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T03:17:41Z","timestamp":1262661461000},"page":"16-22","source":"Crossref","is-referenced-by-count":41,"title":["Update on Frontotemporal Dementia"],"prefix":"10.1097","volume":"16","author":[{"given":"Zoe","family":"Arvanitakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210211","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","article-title":"Prevalence of Alzheimer disease in a community population of older persons: higher than previously reported.","volume":"262","author":"Evans","year":"1989","journal-title":"JAMA"},{"key":"R3-3-20210211","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.archger.2008.06.005","article-title":"Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports.","volume":"49","author":"Brunnstr\u00f6m","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"R4-3-20210211","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons.","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"R5-3-20210211","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/brain\/awg204","article-title":"Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.","volume":"126","author":"Rosso","year":"2003","journal-title":"Brain"},{"key":"R6-3-20210211","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1212\/01.WNL.0000078928.20107.52","article-title":"Survival in frontotemporal dementia.","volume":"61","author":"Hodges","year":"2003","journal-title":"Neurology"},{"key":"R7-3-20210211","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","article-title":"Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.","volume":"58","author":"McKhann","year":"2001","journal-title":"Arch Neurol"},{"key":"R8-3-20210211","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archneur.1990.00530120075013","article-title":"Primary progressive aphasia. Longitudinal course, neuropsychological profile, and language features.","volume":"47","author":"Weintraub","year":"1990","journal-title":"Arch Neurol"},{"key":"R9-3-20210211","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000077155","article-title":"Relationship between frontotemporal dementia and corticobasal degeneration\/progressive supranuclear palsy.","volume":"17","author":"Kertesz","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R10-3-20210211","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia.","volume":"57","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-3-20210211","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"R12-3-20210211","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0749-0690(05)70070-7","article-title":"Focal degenerative dementia syndromes.","volume":"17","author":"Arvanitakis","year":"2001","journal-title":"Clinics Geriatr Med"},{"key":"R13-3-20210211","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/01.wnl.0000247630.29222.34","article-title":"Behavioral features in semantic dementia vs. other forms of progressive aphasias.","volume":"67","author":"Rosen","year":"2006","journal-title":"Neurology"},{"key":"R14-3-20210211","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17.","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"R15-3-20210211","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside.","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"R16-3-20210211","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cortex.2007.08.018","article-title":"Repeat and point: differentiating semantic dementia from progressive non-fluent aphasia.","volume":"44","author":"Hodges","year":"2008","journal-title":"Cortex"},{"key":"R17-3-20210211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R18-3-20210211","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice parameter: diagnosis of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"R19-3-20210211","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.wnl.0000320506.79811.da","article-title":"The logopenic\/phonological variant of primary progressive aphasia.","volume":"71","author":"Gorno-Tempini","year":"2008","journal-title":"Neurology"},{"key":"R20-3-20210211","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4088\/JCP.v69n0109","article-title":"Spontaneous social behaviors discriminate behavioral dementias from psychiatric disorders and other dementias.","volume":"69","author":"Rankin","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R21-3-20210211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000098562","article-title":"Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.","volume":"23","author":"Heidler-Gary","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R22-3-20210211","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/WAD.0b013e31815bf8a5","article-title":"Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes.","volume":"21","author":"Wicklund","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R23-3-20210211","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000110577","article-title":"Screening for frontotemporal dementias and Alzheimer disease with the Philadelphia Brief Assessment of Cognition: a preliminary analysis.","volume":"24","author":"Libon","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R24-3-20210211","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuroimage.2008.03.050","article-title":"Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.","volume":"41","author":"Davatzikos","year":"2008","journal-title":"Neuroimage"},{"key":"R25-3-20210211","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archneur.64.6.830","article-title":"Accuracy of the clinical evaluation for frontotemporal dementia.","volume":"64","author":"Mendez","year":"2007","journal-title":"Arch Neurol"},{"key":"R26-3-20210211","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2005.11.002","article-title":"Decline in cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET study.","volume":"28","author":"Diehl-Schmid","year":"2007","journal-title":"Neurobiol Aging"},{"issue":"suppl 1","key":"R27-3-20210211","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jalz.2007.10.004","article-title":"Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer disease.","volume":"4","author":"Foster","year":"2008","journal-title":"Alzheimer's Dement"},{"key":"R28-3-20210211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/WAD.0b013e3181610fea","article-title":"Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.","volume":"22","author":"Kapaki","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R29-3-20210211","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00415-008-0565-8","article-title":"Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.","volume":"255","author":"Llad\u00f3","year":"2008","journal-title":"J Neurol"},{"key":"R30-3-20210211","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.64.11.1601","article-title":"Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia.","volume":"64","author":"Grossman","year":"2007","journal-title":"Arch Neurol"},{"key":"R31-3-20210211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"R32-3-20210211","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1073\/pnas.94.8.4113","article-title":"Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.","volume":"94","author":"Spillantini","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-3-20210211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.40.2.251","article-title":"Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia.","volume":"40","author":"Knopman","year":"1990","journal-title":"Neurology"},{"key":"R34-3-20210211","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000077168","article-title":"Hippocampal sclerosis and ubiquitin-positive inclusions in dementia lacking distinctive histopathology.","volume":"17","author":"Josephs","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R35-3-20210211","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.21388","article-title":"Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.","volume":"63","author":"Mesulam","year":"2008","journal-title":"Ann Neurol"},{"key":"R36-3-20210211","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/ana.20873","article-title":"Frontotemporal dementia: clinicopathological correlations.","volume":"59","author":"Forman","year":"2006","journal-title":"Ann Neurol"},{"key":"R37-3-20210211","doi-asserted-by":"crossref","first-page":"15997","DOI":"10.1073\/pnas.0808084105","article-title":"Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia.","volume":"105","author":"Ittner","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R38-3-20210211","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/brain\/awm331","article-title":"Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.","volume":"131","author":"Pickering-Brown","year":"2008","journal-title":"Brain"},{"key":"R39-3-20210211","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archneur.64.8.1148","article-title":"Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.","volume":"64","author":"Van Deerlin","year":"2007","journal-title":"Arch Neurol"},{"key":"R40-3-20210211","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.410410606","article-title":"Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants.","volume":"41","author":"Foster","year":"1997","journal-title":"Ann Neurol"},{"key":"R41-3-20210211","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.parkreldis.2006.10.007","article-title":"Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation).","volume":"13","author":"Arvanitakis","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"R42-3-20210211","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00019052-200108000-00010","article-title":"Recent advances in the understanding of tau protein and movement disorders.","volume":"14","author":"Arvanitakis","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"R43-3-20210211","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2008-14406","article-title":"Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments.","volume":"14","author":"Brunden","year":"2008","journal-title":"J Alzheimer's Dis"},{"key":"R44-3-20210211","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"R45-3-20210211","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","article-title":"Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.","volume":"442","author":"Cruts","year":"2006","journal-title":"Nature"},{"key":"R46-3-20210211","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/nen.0b013e3181567873","article-title":"Corticobasal syndrome associated with the A9D Progranulin mutation.","volume":"66","author":"Spina","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"R47-3-20210211","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(07)70221-1","article-title":"Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C\u2013>T (Arg493X) mutation: an international initiative [erratum in Lancet Neurol. 2007;6:1037].","volume":"6","author":"Rademakers","year":"2007","journal-title":"Lancet Neurol"},{"key":"R48-3-20210211","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/humu.20681","article-title":"Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.","volume":"29","author":"Mukherjee","year":"2008","journal-title":"Hum Mutat"},{"key":"R49-3-20210211","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awn012","article-title":"Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.","volume":"131","author":"Le Ber","year":"2008","journal-title":"Brain"},{"key":"R50-3-20210211","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awl271","article-title":"The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.","volume":"129","author":"MacKenzie","year":"2006","journal-title":"Brain"},{"key":"R51-3-20210211","doi-asserted-by":"crossref","first-page":"10530","DOI":"10.1523\/JNEUROSCI.3421-07.2007","article-title":"Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.","volume":"27","author":"Zhang","year":"2007","journal-title":"J Neurosci"},{"key":"R52-3-20210211","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-008-0395-x","article-title":"TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD.","volume":"116","author":"Roeber","year":"2008","journal-title":"Acta Neuropathol"},{"key":"R53-3-20210211","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.WNL.0000034763.54161.1F","article-title":"Chromosome 3 linked frontotemporal dementia (FTD-3).","volume":"59","author":"Gydesen","year":"2002","journal-title":"Neurology"},{"key":"R54-3-20210211","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/nen.0b013e3181567f02","article-title":"A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3.","volume":"66","author":"Holm","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"R55-3-20210211","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1006\/mgme.2001.3256","article-title":"Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.","volume":"74","author":"Kovach","year":"2001","journal-title":"Mol Genet Metabol"},{"key":"R56-3-20210211","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1399-0004.2007.00887.x","article-title":"Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.","volume":"72","author":"Watts","year":"2007","journal-title":"Clin Genet"},{"key":"R57-3-20210211","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1212\/WNL.55.10.1577","article-title":"Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation.","volume":"55","author":"Raux","year":"2000","journal-title":"Neurology"},{"key":"R58-3-20210211","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/brain\/awl268","article-title":"Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in programulin: a clinicopathologic study.","volume":"129","author":"Boeve","year":"2006","journal-title":"Brain"},{"key":"R59-3-20210211","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4088\/JCP.v58n0506","article-title":"Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.","volume":"58","author":"Swartz","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R60-3-20210211","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000067021","article-title":"Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms: a randomized, controlled, open 14-month study.","volume":"49","author":"Moretti","year":"2003","journal-title":"Eur Neurol"},{"key":"R61-3-20210211","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00213-003-1686-5","article-title":"Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.","volume":"172","author":"Deakin","year":"2004","journal-title":"Psychopharmacol"},{"key":"R62-3-20210211","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000077171","article-title":"Frontotemporal dementia: a randomised, controlled trial with trazodone.","volume":"17","author":"Lebert","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R63-3-20210211","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/gps.894","article-title":"Pharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemide.","volume":"18","author":"Adler","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"R64-3-20210211","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00002512-200421140-00003","article-title":"Rivastigmine in frontotemporal dementia: an open-label study.","volume":"21","author":"Moretti","year":"2004","journal-title":"Drugs Aging"},{"key":"R65-3-20210211","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.JGP.0000231744.69631.33","article-title":"Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia.","volume":"15","author":"Mendez","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"R66-3-20210211","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000113034","article-title":"Galantamine in frontotemporal dementia and primary progressive aphasia.","volume":"25","author":"Kertesz","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R67-3-20210211","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/gps.1973","article-title":"A 6-month, open-label study of memantine in patients with frontotemporal dementia.","volume":"23","author":"Diehl-Schmid","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"R68-3-20210211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jalz.2007.06.001","article-title":"New directions for frontotemporal dementia drug discovery.","volume":"4","author":"Trojanowski","year":"2008","journal-title":"Alzheimer's Dement"},{"key":"R69-3-20210211","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0406361102","article-title":"Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.","volume":"102","author":"Zhang","year":"2005","journal-title":"PNAS USA"},{"key":"R70-3-20210211","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/WAD.0b013e31815c345e","article-title":"Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies.","volume":"21","author":"Boxer","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R71-3-20210211","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2008-1061625","article-title":"Treatment for anomia in semantic dementia.","volume":"29","author":"Henry","year":"2008","journal-title":"Semin Speech Lang"},{"key":"R72-3-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096317","article-title":"Driving abilities in frontotemporal dementia patients.","volume":"23","author":"de Simone","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R74-3-20210211","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/13607860802224334","article-title":"Support to family carers of patients with frontotemporal dementia.","volume":"12","author":"Rosness","year":"2008","journal-title":"Aging Ment Health"},{"key":"R75-3-20210211","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/1533317506293259","article-title":"The psychosocial impact of young onset dementia on spouses.","volume":"21","author":"Kaiser","year":"2006","journal-title":"Am J Alzheimer's Dis Other Demen"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/NRL.0b013e3181b1d5c6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:13:22Z","timestamp":1786040002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00127893-201001000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e3181b1d5c6","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}